Generalized anxiety disorder (GAD) is a chronic condition marked by persistent, excessive anxiety and difficulty controlling everyday worries. GAD is one of the most common psychiatric disorders with a past-year prevalence among US adults of approximately 10%.
This is evidently why JAMA Psychiatry could be on board with dosing 35 million Americans with LSD. The authoritative on-line publication currently features a study by a dozen authors, nine of whom are affiliated with MindMed, the company which describes itself for investors as "...a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders." LSD is their novel product, merely renamed and not much re-branded, as "MM120, lysergide-D tartrate."
MindMed is listed on the NASDAQ exchange under the symbol MNMD. The stock traded as high as $150 per share in 2017, but is currently quoted at about $9.25.
Back in May, 2021, the company announced a partnership with the Chopra Foundation of Deepak Chopra, "...to educate and build public awareness around the use of psychedelic medicines to treat mental illness." Chopra claims that a person may attain perfect health, a condition completely free from disease, to never feel pain, and not age or die. MindMed's vision of LSD is similar, seeing the drug as a panacea, not only to treat GAD, but also for depression, post traumatic stress, fear of dying, addiction, personality disorders, pain relief, and even spiritual troubles.
If this sounds more like Haight-Ashbury 1967, than Twenty-first Century scientific medicine, that's because it is. Calling acid "MM120" doesn't change the fact that when you take it, you become psychotic for at least eight hours. Back in the day, LSD was officially known to psychiatrists as a "psychotomimetic" drug, literally meaning that its effects mimic psychosis. It was also considered a weapon of psychological warfare by the CIA, and praised as "dynamite" by Richard Helms and Sid Gottlieb.
MindMed's "medicine" for GAD is not a different drug, it is LSD. It breaks apart and scrambles the pieces of a mind, so that some expert who knows better than ordinary humans can then install another mind in its place. In over 180 press releases since 2021, MindMed has never cited science which explains their project in any terms clearer than that.
JAMA Psychiatry now becomes a co-conspirator with some of the most notorious human rights criminals in history, and a contributor to the harm that will be wrecked upon the American public and culture by psychiatric use of psychedelic drugs.
They publish MindMed's dark "clinical study" but instantly refuse my comments on the ethical dilemmas of antipsychotic medications.
And we can be sure they'll never admit why.
No comments:
Post a Comment